301520.SZ
万邦医药
SZSE · M 科研服务 · CN
CNY 77.10
+8.36%Margins
Gross margin
22.8%
EBITDA margin
26.2%
EBIT margin
11.9%
Net margin
10.4%
FCF margin
-6.7%
1.6%
Return on equity
1.5%
Return on assets
—
Return on invested capital
0.15x
Asset turnover
CNY 4.6M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026